Industries > Pharma > Global Antifungal Drugs Market Forecast 2019-2029

Back to Pharma Reports

Global Antifungal Drugs Market Forecast 2019-2029

Azoles, Echinocandins, Polyenes, Allylamines, Voriconazole, Posaconazole, Clotrimazole, Isavuconazole, Fluconazole, Caspofungin, Micagunfin, Amphotericin, Lamisil, Dermatophytosis, Aspergillosis, Candidiasis

PUBLISHED: 04 June 2019

PAGES: 203

PRODUCT CODE: PHA0425

SUBMARKET: Therapeutic Drugs

SKU: PHA0425 Categories: Pharma, Therapeutic Drugs Tags: PHA0422, PHA0425, PHA0459, PHA0622

The global antifungal drugs market is estimated to have reached $14bn in 2018 and is expected to grow at a CAGR of 3.8% during the forecast period. In 2018, the global antifungal drugs market was dominated by Azoles.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 203-page report you will receive 85 tables and 101 figures– all unavailable elsewhere.

The 203-page report provides clear detailed insight into the antifungal drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Antifungal Drugs Market forecasts from 2019-2029

• Global Antifungal Drugs Market forecasts from 2019-2029 by Segment:
• Azoles
• Echinocandins
• Polyenes
• Allylamines
• Others

• Global Antifungal Drugs Market forecasts from 2019-2029 by Indication:
• Dermatophytosis
• Aspergillosis
• Candidiasis
• Others

• Global Antifungal Drugs Market forecasts from 2019-2029 by Drugs:
• Voriconazole
• Posaconazole
• Clotrimazole
• Isavuconazole
• Fluconazole
• Caspofungin
• Micagunfin
• Amphotericin
• Lamisil

• Global Antifungal Drugs Market forecasts from 2019-2029 by regional and national market:
• North America: The U.S., Canada
• Europe: Germany, France, the UK, Italy, Spain, Rest of Europe
• Asia-Pacific: Japan, China, India, Rest of APAC
• Latin America: Brazil, Mexico, Rest of Latin America

Each regional market is further segmented into Azoles, Echinocandins, Polyenes, Allylamines, Dermatophytosis, Aspergillosis, Candidiasis, Others

• Profiles of the selected leading companies:
• Abbott Laboratories
• Bayer AG
• Enzon Pharmaceuticals, Inc.
• Gilead Sciences, Inc.
• GlaxoSmithKline
• Kramer Laboratories, Inc.
• Merck & Co., Inc.
• Novartis AG
• Pfizer
• Sanofi S.A.

• Antifungal Drugs R&D Pipeline

• Key Questions Answered by this Report:
• How is the Antifungal Drugs market evolving?
• How will each Antifungal Drugs submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2029?
• How will the market shares for each Antifungal Drugs submarket develop from 2019 to 2029?
• Will leading national Antifungal Drugs markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2029 and which geographical region will lead the market in 2029?
• Who are the leading players?
• How will the industry evolve during the period between 2019 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the global antifungal drugs Market. You find data, trends and predictions.

Buy our report today Global Antifungal Drugs Market Analysis: Azoles, Echinocandins, Polyenes, Allylamines, Voriconazole, Posaconazole, Clotrimazole, Isavuconazole, Fluconazole, Caspofungin, Micagunfin, Amphotericin, Lamisil, Dermatophytosis, Aspergillosis, Candidiasis.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

1. Report Overview

1.1 Global Antifungal Drugs Market Overview

1.2 Overview of Findings

1.3 Structure of the Report

1.4 Global Antifungal Drugs Market Segmentation

1.5 Why You Should Read This Report

1.6 How This Report Delivers

1.7 Key Questions Answered by This Analytical Report

1.8. Who is This Report For?

1.9 Methodology

1.10 Associated Visiongain Reports

1.11 About Visiongain

2. Introduction to Antifungal Drugs

2.1. What are Antifungal Drugs?

2.2. The Evolution of Antifungal Drug Therapy?

2.2.1 History of antifungal therapy

2.2.2. Clinical Indications

2.3. Antifungal Drugs Segmentation

2.3.1 Azoles

2.3.1.1 Overview of Clinical Uses:

2.3.1.2. Indication Insights

2.3.2. Echinocandins

2.3.2.1 Echinocandins and Relevance in Biofilms

2.3.3 Polyenes

2.3.4. Allylamines

2.4. Common Invasive Fungal Diseases

2.5. Currently available antifungal drugs

2.6. Market Dynamics

2.6.1 Drivers

2.6.1.1. Increasing incidence of fungal infections

2.6.1.2. Increase in awareness

2.6.2. Restraint

2.6.2.1 Increasing resistance to antifungal drugs

3. Antifungal Drugs Market, 2019-2029

3.1 Global Antifungal Drugs: Market Overview

3.1.1 Segments within the Global Antifungal Drugs Market

3.2 The Global Antifungal Drugs Market in 2017 and 2018

3.3 Global Antifungal Drugs: Market Forecast 2019-2029

3.3.1 Market Sectors That Will Drive Antifungal Drugs Growth

3.3.2 Global Antifungal Drugs Market - Changing Market Shares by Sector 2019-2029

3.4 Global Antifungal Drugs Market by Indication: Sales Forecast 2019-2029

3.4.1 Global Antifungal Drugs Market - Changing Market Shares by Sector 2019-2029

4. Leading Drugs in the Antifungal Drugs Market 2019-2029

4.1 The Global Antifungal Drugs Market in 2017 and 2018

4.2 Azoles

4.2.1. Voriconazole (Vfend)

4.2.2 Voriconazole (Vfend): Sales Forecast 2019-2029

4.2.3 Posaconazole (Noxafil)

4.2.4 Posaconazole (Noxafil): Sales Forecast 2019-2029

4.2.5. Clotrimazole (Canesten)

4.2.6. Clotrimazole (Canesten): Sales Forecast 2019-2029

4.2.7. Isavuconazole (CRESEMBA)

4.2.8. Isavuconazole (CRESEMBA): Sales Forecast 2019-2029

4.2.9. Fluconazole (Diflucan)

4.2.10. Fluconazole (Diflucan): Sales Forecast 2019-2029

4.3 Echinocandins

4.3.1. Caspofungin (Cancidas)

4.3.2. Caspofungin (Cancidas): Sales Forecast 2019-2029

4.3.3. Micafungin (Mycamine/ Funguard)

4.3.4. Micafungin (Mycamine/ Funguard): Sales Forecast 2019-2029

4.4 Polyenes

4.4.1. AmBisome (Gilead Sciences)

4.4.2 AmBisome: Sales Forecast 2019-2029

4.5 Allylamines

4.5.1. Lamisil (terbinafine) - Novartis

4.5.1.1 Lamisil Patent Expiry

4.5.1.2 Lamisil Sales Affected by Novartis Manufacturing Problems

4.5.1.3. Lamisil: Sales Forecast 2019-2029

5. Leading National Markets 2019-2029

5.1. Geographical Breakdown of the World Antifungal Drugs Market

5.2 World Antifungal Drugs Market: Regional Forecast 2019-2029

5.2.1 How Will Regional Market Shares Change to 2029?

6. North America Antifungal Drugs Market 2019-2029

6.1. US Antifungal Drugs Market: Market Forecast 2019-2029

6.2. Canada Antifungal Drugs Market: Trends and Developments

7. Europe Antifungal Drugs Market 2019-2029

7.1 Europe Markets: Changing Market Shares by Country, 2019-2029

7.2 Germany

7.2.1 German Antifungal Drugs Market: Market Forecast 2019-2029

7.3. France Antifungal Drugs Market Forecast 2019-2029

7.4. U.K.

7.4.1. U.K. Antifungal Drugs Market Forecast 2019-2029

7.5 Italy

7.5.1 Italy Antifungal Drugs Market Forecast 2019-2029

7.6. Spain Antifungal Drugs Market Forecast 2019-2029

7.7. Rest of Europe Antifungal Drugs Market Forecast 2019-2029

8. Asia-Pacific Antifungal Drugs Market 2019-2029

8.1. Japan Antifungal Drugs Market: Trends and Developments

8.1.1 Japanese Antifungal Drugs Market Forecast 2019-2029

8.2 China

8.2.1 Chinese Antifungal Drugs Market Forecast 2019-2029

8.3. India

8.3.1 Indian Antifungal Drugs Market Forecast 2019-2029

8.4. Rest of Asia-Pacific Antifungal Drugs Market: Trends and Developments

9. Latin America Antifungal Drugs Market 2019-2029

9.1 Brazil: Focus on Domestic Drug Manufacturing

9.1.1 Brazil Antifungal Drugs Market Forecast 2019-2029

9.2. Mexico Antifungal Drugs Market: Trends and Developments

9.3. Rest of Latin America Antifungal Drugs Market: Trends and Developments

10. Middle East & Africa Antifungal Drugs Market 2019-2029

10.1. Saudi Arabia Antifungal Drugs Market Forecast 2019-2029

10.2. South Africa Antifungal Drugs Market Forecast 2019-2029

10.3. Rest of Middle East & Africa Antifungal Drugs Market Forecast 2019-2029

11. Leading Companies in the Antifungal Drugs Market, 2019

11.1 Novartis AG

11.1.1 Novartis: Antifungal Drugs Product Portfolio

11.1.2 Novartis AG: Financial Overview

11.1.3 Novartis AG: Recent Transactions Summary

11.2. Pfizer, Inc.

11.2.1 Pfizer, Inc.: Antifungal Drugs Portfolio

11.2.2 Pfizer, Inc.: Financial Overview

11.2.3 Pfizer, Inc.: Recent Developments

11.3. Sanofi S.A.

11.3.1 Sanofi S.A.: Antifungal Drugs Portfolio

11.3.2 Sanofi S.A.: Financial Overview

11.3.3 Sanofi S.A.: Recent Developments

11.4. GlaxoSmithKline plc

11.4.1 GlaxoSmithKline plc: Antifungal Drugs Portfolio

11.4.2 GlaxoSmithKline plc: Financial Overview

11.4.3 GlaxoSmithKline plc: Recent Transactions Summary

11.5. Bayer AG

11.5.1 Bayer AG: Antifungal Drugs Portfolio

11.5.2 Bayer AG: Financial Overview

11.5.3 Bayer AG: Recent Transactions Summary

11.6. Merck & Co., Inc.

11.6.1 Merck & Co., Inc.: Antifungal Drugs Portfolio

11.6.2 Merck & Co., Inc.: Financial Overview

11.6.3 Merck & Co., Inc.: Recent Transactions Summary

11.7. Abbott Laboratories

11.7.1 Abbott Laboratories: Antifungal Drugs Product Portfolio

11.7.2 Financial Overview

11.7.3 Recent Transactions Summary

11.8. Gilead Sciences, Inc.

11.8.1 Gilead Sciences, Inc.: Antifungal Drugs Product Portfolio

11.8.2 Financial Overview

11.8.3 Recent Transactions Summary

11.9. Enzon Pharmaceuticals, Inc.

11.9.1 Enzon Pharmaceuticals, Inc.:Antifungal Drugs Product Portfolio

11.9.2 Financial Overview

11.10. Kramer Laboratories, Inc.

11.10.1 Kramer Laboratories, Inc.: Antifungal Drugs Product Portfolio

11.10.2 Recent Transactions Summary

12. Antifungal Drugs R&D Pipeline 2018

12.1. Antifungal drug development considerations

12.2. The antifungal pipeline

13. Conclusions

13.1 The World Antifungal Drugs Market in 2017 and 2018

13.1.1 Current Leading Antifungal Drugs Segments

13.1.2 Leading Regional Markets

13.2 World Antifungal Drugs Market Forecast 2019-2029

13.3 The Future of the Antifungal Drugs Market?

Appendices

Associated Visiongain Reports

Visiongain Report Sales Order Form

About Visiongain

Report Evaluation Form

List of Tables

Table 2.1 Classification of Anti-Fungal Agents

Table 2.1 Azoles as Antifungal Agents

Table 2.3 Toxicity OF Azoles

Table 2.4 Common Invasive Fungal Diseases

Table 3.1 The Global Antifungal Drugs Market: Revenue ($m) and Market Shares (%) by Sector, 2017 and 2018

Table 3.2 Global Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 3.3 Global Antifungal Drugs Market by Sector: CAGR (%), 2019-2023, 2023-2029, 2019-2029

Table 3.4 The Global Antifungal Drugs Market: Revenue ($m) by Sector, 2018, 2023 and 2029

Table 3.5 Global Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 3.6 The Global Antifungal Drugs Market: Revenue ($m) by Sector, 2018, 2023 and 2029

Table 4.1 The Global Antifungal Drugs Market: Revenue ($m) and Market Shares (%) by Sector, 2017 and 2018

Table 4.2 Global Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 4.3 Global Azoles Market Forecast: Revenues ($m) AGR (%), AGR (%), 2019-2029

Table 4.4 Voriconazole (Vfend) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 4.5 Posaconazole (Noxafil) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 4.6 Clotrimazole (Canesten) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 4.7 Isavuconazole (CRESEMBA) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 4.8 Fluconazole (Diflucan) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 4.9 Global Echinocandins Market Forecast: Revenues ($m), AGR (%), AGR (%), 2019-2029

Table 4.10 Caspofungin (Cancidas) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 4.11 Micafungin (Mycamine/ Funguard) Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 4.12 Global Polyenes Market Forecast: Revenues ($m) AGR (%), AGR (%), 2019-2029

Table 4.13 AmBisome Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 4.14 Global Allylamines Market Forecast: Revenues ($m), AGR (%), AGR (%), 2019-2029

Table 4.15 Lamisil Sales Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 5.1 Global Antifungal Drugs Market by Region: Revenue ($m), 2017 and 2018

Table 5.2 Global Antifungal Drugs Market Forecast by Region: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 5.3 Global Antifungal Drugs Market by Region: CAGR (%), 2019-2023, 2023-2029, 2019-2029

Table 5.4 Global Antifungal Drugs Market by Region: CAGR (%), 2019-2023, 2023-2029, 2019-2029

Table 6.1 North America Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 6.2 North America Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 6.3 North America Antifungal Drugs Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 6.4 U.S. Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 6.5 Canada Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 7.1 Europe Antifungal Drugs Market by Country/Sub-region: Revenue ($m) and Market Share (%), 2017

Table 7.2 Europe Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 7.3 Global Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 7.4 Europe Antifungal Drugs Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 7.5 Europe Antifungal Drugs Market by Country/Sub-region: CAGR (%), 2019-2023, 2023-2029, 2019-2029

Table 7.6 Germany Antifungal Drugs Market Forecast: ($m, AGR %, CAGR %), 2019-2029

Table 7.7 France Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 7.8 U.K. Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029

Table 7.9 Italy Antifungal Drugs Market Forecast: ($m, AGR %, CAGR %), 2019-2029

Table 7.10 Spain Antifungal Drugs Market Forecast: ($m, AGR %, CAGR %), 2019-2029

Table 7.11 Rest of Europe Antifungal Drugs Market Forecast: ($m, AGR %, CAGR %), 2019-2029

Table 8.1 Asia-Pacific Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 8.2 Asia-Pacific Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 8.3 Asia-Pacific Antifungal Drugs Market Forecast by Country: Revenues ($ m), AGR (%), CAGR (%), 2019-2029

Table 8.4 Japan Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029

Table 8.5 China Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029

Table 8.6 India Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029

Table 8.7 Rest of Asia-Pacific Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029

Table 9.1 Latin America Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 9.2 Latin America Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 9.3 Latin America Antifungal Drugs Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 9.4 Brazil Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029

Table 9.5 Mexico Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029

Table 9.6 Rest of Latin America Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029

Table 10.1 Middle East and Africa Antifungal Drugs Market Forecast: Revenues ($ m), AGR (%), CAGR (%), 2019-2029

Table 10.2 Middle East & Africa Antifungal Drugs Market Forecast by Indication: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 10.3 Middle East & Africa (MEA) Antifungal Drugs Market Forecast by Country: Revenues ($m), AGR (%), CAGR (%), 2019-2029

Table 10.4 Saudi Arabia Antifungal Drugs Market Forecast by Country: Revenues ($ m), AGR (%), CAGR (%), 2019-2029

Table 10.5 South Africa Antifungal Drugs Market Forecast: ($m, AGR%, CAGR%), 2019-2029

Table 10.6 Rest of MEA Antifungal Drugs Market Forecast; ($m, AGR%, CAGR%), 2019-2029

Table 11.1 Novartis AG: Overview

Table 11.2 Novartis AG: Revenue ($m), AGR (%), 2014-2018

Table 11.3 Pfizer, Inc.: Overview

Table 11.4 Pfizer, Inc.: Revenue ($m), AGR (%), 2014-2018

Table 11.5 Sanofi S.A.: Overview

Table 11.6 Sanofi S.A.: Revenue ($m), AGR (%), 2014-2018

Table 11.7 GlaxoSmithKline plc: Overview

Table 11.8 GlaxoSmithKline plc: Revenue ($m), AGR (%), 2014-2018

Table 11.9 Bayer AG: Overview

Table 11.10 Bayer AG: Revenue ($m), AGR (%), 2014-2018

Table 11.11 Merck & Co., Inc.: Overview

Table 11.12 Merck & Co., Inc.: Revenue ($m), AGR (%), 2014-2018

Table 11.13 Abbott Laboratories: Overview

Table 11.14 Abbott Laboratories: Revenue ($m), AGR (%), 2014-2018

Table 11.15 Gilead Sciences, Inc.: Overview

Table 11.16 Gilead Sciences, Inc.: Revenue ($m), AGR (%), 2014-2018

Table 11.17 Enzon Pharmaceuticals, Inc.: Overview, 2019

Table 11.18 Enzon Pharmaceuticals, Inc.: Revenue ($m), AGR (%), 2014-2018

Table 11.19 Kramer Laboratories, Inc.: Overview

Table 12.1 Pipeline R&D Products, 2018

Table 12.2 Pipeline R&D Products, 2018

List of Figures

Figure 1.1 Global Antifungal Drugs Market Segmentation Overview

Figure 2.1 Common invasive fungal diseases

Figure 3.1 The Global Antifungal Drugs Market Forecast by Sector: Revenue ($m), 2017 and 2018

Figure 3.2 The Global Antifungal Drugs Market Forecast: Revenue ($m), 2017 and 2018

Figure 3.3 Global Antifungal Drugs Market Forecast: Revenue ($m), AGR (%), 2019-2029

Figure 3.4 The Global Antifungal Drugs Market Forecast: CAGR (%) by Sector, 2019-2023

Figure 3.5 The Global Antifungal Drugs Market Forecast: CAGR (%) by Sector, 2023-2029

Figure 3.6 The Global Antifungal Drugs Market Forecast: CAGR (%) by Sector, 2019-2029

Figure 3.7 The Global Antifungal Drugs Market: Revenue ($m) by Sector, 2018, 2023 and 2029

Figure 3.8 The Global Antifungal Drugs Market: Market Share (%) by Sector, 2018

Figure 3.9 The Global Antifungal Drugs Market: Market Share (%) by Sector, 2023

Figure 3.10 The Global Antifungal Drugs Market: Market Share (%) by Sector, 2029

Figure 3.11 The Global Antifungal Drugs Market: Revenue ($m) by Sector, 2018, 2023 and 2029

Figure 3.12 The Global Antifungal Drugs Market: Market Share (%) by Sector, 2018

Figure 3.13 The Global Antifungal Drugs Market: Market Share (%) by Sector, 2023

Figure 3.14 The Global Antifungal Drugs Market: Market Share (%) by Sector, 2029

Figure 4.1 The Global Antifungal Drugs Market Forecast by Sector: Revenue ($m), 2017 and 2018

Figure 4.2 Global Azoles Market Forecast: Revenue ($m), AGR (%), 2019-2029

Figure 4.3 Global Voriconazole (Vfend) Market Forecast: Revenue ($m) and AGR (%), 2019-2029

Figure 4.4 Global Posaconazole (Noxafil) Market Forecast: Revenue ($m) and AGR (%), 2019-2029

Figure 4.5 Global Clotrimazole (Canesten) Market Forecast: Revenue ($m) and AGR (%), 2019-2029

Figure 4.6 Global Isavuconazole (CRESEMBA) Market Forecast: Revenue ($m) and AGR (%), 2019-2029

Figure 4.7 Global Fluconazole (Diflucan) Market Forecast: Revenue ($m) and AGR (%), 2019-2029

Figure 4.8 Global Echinocandins Market Forecast: Revenue ($m), AGR (%), 2019-2029

Figure 4.9 Global Caspofungin (Cancidas) Market Forecast: Revenue ($m) and AGR (%), 2019-2029

Figure 4.10 Global Micafungin (Mycamine/ Funguard) Market Forecast: Revenue ($m) and AGR (%), 2019-2029

Figure 4.11 Global Polyenes Market Forecast: Revenue ($m), AGR (%), 2019-2029

Figure 4.12 Global AmBisome Market Forecast: Revenue ($m) and AGR (%), 2019-2029

Figure 4.13 Global Allylamines Market Forecast: Revenue ($m), AGR (%), 2019-2029

Figure 4.14 Global Lamisil Market Forecast: Revenue ($m) and AGR (%), 2019-2029

Figure 5.1 World Antifungal Drugs Market: Revenues ($m) by Region, 2017

Figure 5.2 World Antifungal Drugs Market: Revenues ($m) by Region, 2018

Figure 5.3 Global Antifungal Drugs Market Forecast: Revenue ($m), AGR (%), 2019-2029

Figure 5.4 World Antifungal Drugs Market: Market Shares (%) by Regional Market, 2018

Figure 5.5 World Antifungal Drugs Market: Market Shares (%) by Regional Market, 2023

Figure 5.6 World Antifungal Drugs Market: Market Shares (%) by Regional Market, 2029

Figure 6.1 North America Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029

Figure 6.2 North America Antifungal Drugs Market: Market Shares (%) by Regional Market, 2018

Figure 6.3 North America Antifungal Drugs Market: Market Shares (%) by Regional Market, 2023

Figure 6.4 North America Antifungal Drugs Market: Market Shares (%) by Regional Market, 2029

Figure 6.5 U.S. Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029

Figure 6.6 Canada Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029

Figure 7.1 Europe Antifungal Drugs Market: Revenues ($m) by Country/Sub-region, 2017

Figure 7.2 Europe Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029

Figure 7.3 Europe Antifungal Drugs Market: Market Shares (%) by Regional Market, 2018

Figure 7.4 Europe Antifungal Drugs Market: Market Shares (%) by Regional Market, 2023

Figure 7.5 Europe Antifungal Drugs Market: Market Shares (%) by Regional Market, 2029

Figure 7.6 Germany Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029

Figure 7.7 France Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029

Figure 7.8 U.K. Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029

Figure 7.9 Italy Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029

Figure 7.10 Spain Antifungal Drugs Market Forecast: Revenues ($ m), AGR (%), 2019-2029

Figure 7.11 Rest of Europe Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029

Figure 8.1 Asia-Pacific Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029

Figure 8.2 Asia-Pacific Antifungal Drugs Market: Market Shares (%) by Regional Market, 2018

Figure 8.3 Asia-Pacific Antifungal Drugs Market: Market Shares (%) by Regional Market, 2023

Figure 8.4 Asia-Pacific Antifungal Drugs Market: Market Shares (%) by Regional Market, 2029

Figure 8.5 Japan Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2017-2029

Figure 8.6 China Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2017-2029

Figure 8.7 India Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029

Figure 8.8 Rest of Asia-Pacific Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029

Figure 9.1 Latin America Antifungal Drugs Market Forecast: Revenues ($ m), AGR (%), 2019-2029

Figure 9.2 Latin America Antifungal Drugs Market: Market Shares (%) by Regional Market, 2018

Figure 9.3 Latin America Antifungal Drugs Market: Market Shares (%) by Regional Market, 2023

Figure 9.4 Latin America Antifungal Drugs Market: Market Shares (%) by Regional Market, 2029

Figure 9.5 Brazil Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029

Figure 9.6 Mexico Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029

Figure 9.7 Rest of Latin America Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029

Figure 10.1 Middle East & Africa (MEA) Antifungal Drugs Market Forecast: Revenues ($m), AGR (%), 2019-2029

Figure 10.2 Middle East & Africa Antifungal Drugs Market: Market Shares (%) by Regional Market, 2018

Figure 10.3 Middle East & Africa Antifungal Drugs Market: Market Shares (%) by Regional Market, 2023

Figure 10.4 Middle East & Africa Antifungal Drugs Market: Market Shares (%) by Regional Market, 2029

Figure 10.5 Saudi Arabia Antifungal Drugs Market Forecast: Revenues ($ m), AGR (%), 2019-2029

Figure 10.6 South Africa Antifungal Drugs Market Forecast: Revenues ($ m), AGR (%), 2019-2029

Figure 10.7 Rest of MEA Antifungal Drugs Market Forecast: Revenues ($ m), AGR (%), 2017-2029

Figure 11.1 Novartis AG: Revenue ($m), AGR (%), 2014-2018

Figure 11.2 Novartis AG: Business Segment Revenue Share (%), 2018

Figure 11.3 Novartis AG by Region Revenue Share (%), 2018

Figure 11.4 Pfizer, Inc.: Revenue ($m), AGR (%), 2014-2018

Figure 11.5 Pfizer, Inc.: Business Segment Revenue Share (%), 2018

Figure 11.6 Pfizer, Inc.: National Revenue Share (%), 2018

Figure 11.7 Sanofi S.A.: Revenue ($m), AGR (%), 2014-2018

Figure 11.8 Sanofi S.A.: Revenue by Region Share (%), 2018

Figure 11.9 Sanofi S.A.: Revenue by Segment Share (%), 2018

Figure 11.10 GlaxoSmithKline plc: Revenue ($m), AGR (%), 2014-2018

Figure 11.11 GlaxoSmithKline plc: Business Segment Revenue Share (%), 2018

Figure 11.12 GlaxoSmithKline plc: Region Revenue Share (%), 2018

Figure 11.13 Bayer AG: Revenue ($m), AGR (%), 2014-2018

Figure 11.14 Bayer AG: Business Segment Revenue Share (%), 2018

Figure 11.15 Bayer AG: Region Revenue Share (%), 2018

Figure 11.16 Merck & Co., Inc.: Revenue ($m), AGR (%), 2014-2018

Figure 11.17 Merck & Co., Inc.: Business Segment Revenue Share (%), 2018

Figure 11.18 Merck & Co., Inc.: Region Revenue Share (%), 2018

Figure 11.19 Abbott Laboratories: Revenue ($m), AGR (%), 2014-2018

Figure 11.20 Abbott Laboratories: Business Segment Revenue Share (%), 2018

Figure 11.21 Abbott Laboratories: Region Revenue Share (%), 2018

Figure 11.22 Gilead Sciences, Inc.: Revenue ($m), AGR (%), 2014-2018

Figure 11.23 Gilead Sciences, Inc.: Region Revenue Share (%), 2018

Figure 11.24 Enzon Pharmaceuticals, Inc.: Revenue ($m), AGR (%), 2014-2018

Figure 13.1 Global Antifungal Drugs Market by Product Type: Market Share (%), 2018

Figure 13.2 Antifungal Drugs Market by Region Share (%), 2017, 2023, 2029

Abbott Laboratories

Alcon

Alere

Amber Luong

AMLadeed

Amplyx Pharmaceuticals

Anacor

Arno Therapeutics

Astellas Pharma

AstraZeneca

Avista Capital Partners

Basilea Pharmaceutica Ltd.

Bayer AG

Bioverativ Inc.

Bumrungrad

Celltrion

Cleveland Clinic

Dana Holdings

Eisai

Enzon Pharmaceuticals, Inc.

Fondazione Telethon (Telethon)

Gilead Sciences

GlaxoSmithKline plc

Hospira

Janssen

Kramer Laboratories, Inc.

LEO Pharma

Merck & Co., Inc.

Mirati Therapeutics

Nizoral

Novartis AG

Novo Nordisk

Ortho-McNeil

Ospedale San Raffaele (OSR)

Pfizer Inc.

PowerVision, Inc.,

Regeneron Pharmaceuticals, Inc.

Sandoz Pharmaceuticals

Sanofi Pasteur

Sanofi S.A.

Shaman Pharmaceuticals

Solvay Pharmaceuticals

Tokuyama Corporation

Trius

Vamed

Vical Incorporated

List of Organisations Mentioned in The Report

Agência Nacional de Vigilância Sanitária

American Depositary Receipts

Antimicrobial Resistance Centre in England

Assiut University

Boston University School of Law

Centers of Disease Control and Prevention (CDC)

Clinical and Laboratory Standards Institute

Department of Infectious Diseases and Medical Microbiology

European Commission

European Economic Area

European Medicines Agency (EMA)

European Organisation for Research and Treatment of Cancer - EORTC

European Society of Clinical Microbiology and Infectious Diseases

European Union

Food and Drug Administration (FDA)

Future Science Group

German Society of Haematology and Oncology

Global Action Fund for Fungal Infections

Government of Abu Dhabi

Infectious Diseases Society of America

Institut für Demoskopie Allensbach (IfD)

Johns Hopkins

Maisonneuve-Rosemont Hospital Research Center

Ministry of Health Italy

Ministry of Health, Labor and Welfare (MHLW)

National Center for Biotechnology Information

National Institute on Aging

National Treasury of Republic of South Africa

Novartis Institutes for BioMedical Research (NIBR)

SENTRY program

Servizio Sanitario Nazionale

Sistema Único de Saúde

Sociedade Brasileira de Infectologia

The University of Texas Health Science Center, Houston

U.S. Department of Health and Human Services

Université de Montréal, Montréal, Canada

University of Arizona

Download sample pages

Complete the form below to download your free sample pages for Global Antifungal Drugs Market Forecast 2019-2029

Download sample pages

Complete the form below to download your free sample pages for Global Antifungal Drugs Market Forecast 2019-2029

Case studies

Need customized work?

Report overview

Methodology

Client testimonials

Pharmaceutical industry associations

American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Connect with us

Visiongain Pharma

Latest Pharma news

Visiongain Publishes Deep Frozen Packaging Logistics Market Report 2023-2033

The global Deep Frozen Packaging Logistics market was valued at US$21,088.3 million in 2022 and is projected to grow at a CAGR of 7.7% during the forecast period 2023-2033.

29 March 2023

READ

Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033

The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.

20 March 2023

READ

Visiongain Publishes eClinical Solutions Market Report 2023-2033

The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.

17 March 2023

READ

Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033

The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.

15 March 2023

READ

Industries > Pharma > Global Antifungal Drugs Market Forecast 2019-2029

Back to Pharma Reports

Global Antifungal Drugs Market Forecast 2019-2029

Azoles, Echinocandins, Polyenes, Allylamines, Voriconazole, Posaconazole, Clotrimazole, Isavuconazole, Fluconazole, Caspofungin, Micagunfin, Amphotericin, Lamisil, Dermatophytosis, Aspergillosis, Candidiasis

Download sample pages

Related reports

Generic Drugs Market Forecast 2019-2029

Global Drug Discovery Outsourcing Market Forecast to 2028

Dermatological Drugs Market Forecast 2018-2028

Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029

Global Inflammatory Bowel Diseases (IBD) Drug Market Forecast 2019-2029

Drug Delivery Technologies Market Forecast 2019-2029

Biologics Market Trends and Forecasts 2018-2028

Translational Regenerative Medicine Market Forecast 2019-2029

mRNA Vaccines and Therapeutics Market Forecast 2019-2029

Global Transplant Market Forecast 2019-2029

Download sample pages

Share

Connect with us

Latest Pharma news

Visiongain Publishes Deep Frozen Packaging Logistics Market Report 2023-2033

Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033

Visiongain Publishes eClinical Solutions Market Report 2023-2033

Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033

Our Clients